Results 131 to 133 of about 6,140 (133)

Enhancing vaccine half-life as a novel strategy for improving immune response durability of subunit vaccines. [PDF]

PLoS Pathog
Shen Z, Li C, Song W, Liu L, Kong Y, Huang A, Bao Q, Ying T, Wu Y.   +8 more
europepmc   +1 more source

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis. [PDF]

Ther Adv Neurol Disord
Zhou Y, Zhou Q, Yue Y, Luo S, Song J, Yan C, He D, Zhang J, Zhu W, Zhao C, Yang H, Wang Q, Xi J.   +12 more
europepmc   +1 more source

Efgartigimod Followed by Telitacicept in Adult Generalized Myasthenia Gravis: A Retrospective Case Series. [PDF]

J Inflamm Res
Zhang Y, Fang Z, Liu Y, Wan B, Zhang Q, Qu X, Pan S, Zhang Y, Dai Y, Yang S, Li J, Zhang X.   +11 more
europepmc   +1 more source